Načítá se...
Gastrointestinal and liver adverse effects of anti-tumoral immune therapy: from recognition to treatment
Anti-tumoral immune therapy consists of monoclonal antibodies that target intra-cellular immune checkpoints—which under normal circumstances, act as regulators of T-cell immunity. By serving as inhibitors of cellular checkpoints, monoclonal antibodies stimulate the immune system thus augmenting the...
Uloženo v:
| Vydáno v: | Gastroenterol Hepatol Bed Bench |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Shaheed Beheshti University of Medical Sciences
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8245835/ https://ncbi.nlm.nih.gov/pubmed/34221257 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|